• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995 - 2015年伊朗慢性阻塞性肺疾病负担趋势:全球疾病负担研究结果

Trends in burden of chronic obstructive pulmonary disease in Iran, 1995-2015: findings from the global burden of disease study.

作者信息

Hashemi Seyed Yaser, Momenabadi Victoria, Faramarzi Ahmad, Kiani Amin

机构信息

Fasa University of Medical Sciences, Fasa, Iran.

Department of Public Health, Bam University of Medical Sciences, Bam, Iran., Bam University of Medical Sciences, Bam, Iran.

出版信息

Arch Public Health. 2020 May 25;78:45. doi: 10.1186/s13690-020-00426-x. eCollection 2020.

DOI:10.1186/s13690-020-00426-x
PMID:32509302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7249692/
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder that progresses over time, and currently it is the fourth leading cause of death across the globe. The World Health Organization (WHO) predicts that the disease will become the third leading cause of death by 2030.

METHODS

Data were retrospectively collected as the Global Burden of Disease (GBD) from 1995 to 2015 and published by the Institute for Health Metrics and Evaluation. We applied DALYs, incidence and prevalence rate to report the burden of COPD in Iran. To assess the statistical significance according to trend, the Cochran-Armitage test was applied.

RESULTS

From 1995 to 2015, there were approximately attributable to COPD in Iran. In both genders and at all ages, the number of DALYs increased significantly from in 1995 to in 2015. The incidence and prevalence rate were 76.65 and 1491.37 per 100,000 population, respectively in both genders in 2015 in Iran. It is noticeable that the number of deaths during the study years, 1995 to 2015, was

CONCLUSIONS

. The majority of DALYs were due to indicating that prevention and early detection, especially in the age groups of 15 to 70 years, should be considered.

摘要

背景

慢性阻塞性肺疾病(COPD)是一种随时间推移而进展的异质性疾病,目前是全球第四大死因。世界卫生组织(WHO)预测,到2030年该疾病将成为第三大死因。

方法

数据作为1995年至2015年全球疾病负担(GBD)进行回顾性收集,并由健康指标与评估研究所发布。我们应用伤残调整生命年(DALYs)、发病率和患病率来报告伊朗慢性阻塞性肺疾病的负担。为了根据趋势评估统计学意义,应用了 Cochr an - Armitage检验。

结果

1995年至2015年期间,伊朗约有……归因于慢性阻塞性肺疾病。在所有年龄组的男性和女性中,伤残调整生命年数从1995年的……显著增加到2015年的……。2015年伊朗男女的发病率和患病率分别为每10万人76.65和1491.37。值得注意的是,1995年至2015年研究期间的死亡人数为……

结论

……。大多数伤残调整生命年归因于……,这表明应考虑预防和早期检测,特别是在15至70岁年龄组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc83/7249692/5bc52661499f/13690_2020_426_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc83/7249692/2e3a821a5d91/13690_2020_426_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc83/7249692/5bc52661499f/13690_2020_426_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc83/7249692/2e3a821a5d91/13690_2020_426_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc83/7249692/5bc52661499f/13690_2020_426_Fig2_HTML.jpg

相似文献

1
Trends in burden of chronic obstructive pulmonary disease in Iran, 1995-2015: findings from the global burden of disease study.1995 - 2015年伊朗慢性阻塞性肺疾病负担趋势:全球疾病负担研究结果
Arch Public Health. 2020 May 25;78:45. doi: 10.1186/s13690-020-00426-x. eCollection 2020.
2
Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies.1995 - 2015年伊朗食管癌负担:全球疾病负担研究结果综述
Med J Islam Repub Iran. 2018 Jul 2;32:55. doi: 10.14196/mjiri.32.55. eCollection 2018.
3
The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016.印度各邦慢性呼吸道疾病负担及其异质性:1990-2016 年全球疾病负担研究。
Lancet Glob Health. 2018 Dec;6(12):e1363-e1374. doi: 10.1016/S2214-109X(18)30409-1. Epub 2018 Sep 12.
4
Global burden of chronic obstructive pulmonary disease attributable to ambient particulate matter pollution and household air pollution from solid fuels from 1990 to 2019.2019 年,源于环境细颗粒物污染和固体燃料室内空气污染的全球慢性阻塞性肺疾病负担。
Environ Sci Pollut Res Int. 2022 May;29(22):32788-32799. doi: 10.1007/s11356-021-17732-8. Epub 2022 Jan 12.
5
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
6
The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.1990年至2010年间伊朗老年人死亡、伤残调整生命年及老年综合征的最主要原因:2010年全球疾病负担研究的结果
Arch Iran Med. 2015 Aug;18(8):462-79.
7
Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017.1990-2017 年伊朗肌肉骨骼疾病负担:2017 年全球疾病负担研究估计。
Arch Osteoporos. 2020 Jul 10;15(1):103. doi: 10.1007/s11657-020-00767-8.
8
Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.1990年至2010年间伊朗丙型肝炎负担:全球疾病负担研究2010的结果
Arch Iran Med. 2015 Aug;18(8):508-14.
9
Global burden of chronic obstructive pulmonary disease attributable to ambient ozone in 204 countries and territories during 1990-2019.1990 - 2019年期间204个国家和地区因环境臭氧导致的慢性阻塞性肺疾病全球负担
Environ Sci Pollut Res Int. 2022 Feb;29(6):9293-9305. doi: 10.1007/s11356-021-16233-y. Epub 2021 Sep 9.
10
Burden of Oral Diseases in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010.1990 - 2010年伊朗口腔疾病负担:全球疾病负担研究2010的结果
Arch Iran Med. 2015 Aug;18(8):486-92.

引用本文的文献

1
Burden analysis of diabetic nephropathy caused by excessive intake of sugar-sweetened beverages in high and low SDI regions.高社会人口指数(SDI)地区和低社会人口指数地区因过量摄入含糖饮料导致的糖尿病肾病负担分析。
Front Public Health. 2025 Jun 27;13:1598278. doi: 10.3389/fpubh.2025.1598278. eCollection 2025.
2
Global, regional, and national burden of myocarditis and its attributable risk factors in 204 countries and territories from 1990 to 2021: updated systematic analysis.1990年至2021年204个国家和地区心肌炎及其归因风险因素的全球、区域和国家负担:最新系统分析
Front Public Health. 2025 Apr 28;13:1542921. doi: 10.3389/fpubh.2025.1542921. eCollection 2025.
3

本文引用的文献

1
How do world and European standard populations impact burden of disease studies? A case study of disability-adjusted life years (DALYs) in Scotland.世界和欧洲标准人口如何影响疾病负担研究?以苏格兰的伤残调整生命年(DALYs)为例
Arch Public Health. 2020 Jan 3;78:1. doi: 10.1186/s13690-019-0383-8. eCollection 2020.
2
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.芬兰慢性阻塞性肺疾病(COPD)的负担:疾病严重程度和嗜酸性粒细胞计数对医疗资源利用的影响。
Int J Chron Obstruct Pulmon Dis. 2019 Oct 25;14:2409-2421. doi: 10.2147/COPD.S222581. eCollection 2019.
3
Longitudinal Association Between the Consumption of Vegetables, Fruits, and Red Meat and Diabetes Disease Burden: An Analysis of Multiple Global Datasets.
蔬菜、水果和红肉消费与糖尿病疾病负担之间的纵向关联:多个全球数据集的分析
Nutrients. 2025 Apr 3;17(7):1256. doi: 10.3390/nu17071256.
4
The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.体重指数对 COPD 死亡率的影响:一项更新的剂量-反应荟萃分析。
Eur Respir Rev. 2024 Nov 27;33(174). doi: 10.1183/16000617.0261-2023. Print 2024 Oct.
5
Features of Atrial Fibrillation Pathogenesis and Prognosis in Chronic Obstructive Pulmonary Patients during the COVID-19 Pandemic.COVID-19大流行期间慢性阻塞性肺疾病患者心房颤动的发病机制和预后特征
Rev Cardiovasc Med. 2023 Feb 6;24(2):51. doi: 10.31083/j.rcm2402051. eCollection 2023 Feb.
6
Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects.基于人脐带间充质干细胞的方法在肺部疾病中的治疗效用:最新进展与前景
World J Stem Cells. 2024 Feb 26;16(2):70-88. doi: 10.4252/wjsc.v16.i2.70.
7
The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021).伊朗北部巴博勒呼吸系统癌症死亡率趋势研究(2013 - 2021年)
Multidiscip Respir Med. 2023 Dec 18;18(1):929. doi: 10.4081/mrm.2023.929. eCollection 2023 Jan 17.
8
Simultaneous UPLC Assay for Oxitropium Bromide and Formoterol Fumarate Dihydrate in Pressurized Metered Dose Inhaler Products for Chronic Obstructive Pulmonary Disease.用于慢性阻塞性肺病的定量吸入气雾剂产品中溴化氧托品和富马酸福莫特罗二水合物的同时 UPLC 测定法。
J AOAC Int. 2024 Mar 1;107(2):242-247. doi: 10.1093/jaoacint/qsad134.
9
Joint modeling of forced vital capacity measures with time to onset of polycythemia among chronic obstructive pulmonary outpatients follows-up: A case of University of Gondar Referral Hospital.慢性阻塞性肺疾病门诊患者随访中用力肺活量测量与红细胞增多症发病时间的联合建模:以贡德尔大学转诊医院为例
Health Sci Rep. 2023 Sep 28;6(10):e1587. doi: 10.1002/hsr2.1587. eCollection 2023 Oct.
10
The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes.全球糖尿病发病率、患病率、死亡率、伤残调整生命年病例数的描述和预测及其年龄标准化率。
J Epidemiol Glob Health. 2023 Sep;13(3):566-576. doi: 10.1007/s44197-023-00138-9. Epub 2023 Jul 3.
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia.
非洲、亚洲和澳大拉西亚地区慢性阻塞性肺疾病患病率的地理分布。
Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1100-1106. doi: 10.5588/ijtld.19.0015.
4
Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study.埃塞俄比亚阿贝斯格地区成年人慢性阻塞性肺疾病(COPD)及其相关因素的患病率:一项横断面研究。
BMC Pulm Med. 2019 Oct 17;19(1):181. doi: 10.1186/s12890-019-0946-z.
5
The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.慢性阻塞性肺疾病(COPD)在美国、欧洲和亚洲的经济负担:文献系统综述的结果。
Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):661-672. doi: 10.1080/14737167.2020.1678385. Epub 2019 Oct 18.
6
[COPD - Smoking is not the only risk factor].[慢性阻塞性肺疾病——吸烟并非唯一风险因素]
MMW Fortschr Med. 2019 Jul;161(13):66-68. doi: 10.1007/s15006-019-0718-y.
7
Most important risk factor missing from COPD score.慢性阻塞性肺疾病(COPD)评分中遗漏的最重要风险因素。
CMAJ. 2019 Apr 1;191(13):E370. doi: 10.1503/cmaj.71663.
8
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
9
Chronic obstructive pulmonary disease and sleep related disorders.慢性阻塞性肺疾病与睡眠相关障碍
Curr Opin Pulm Med. 2017 Mar;23(2):124-128. doi: 10.1097/MCP.0000000000000351.
10
Applying QMRA and DALY to assess health risks from river bathing.应用定量微生物风险评估和伤残调整生命年评估河流沐浴带来的健康风险。
Int J Hyg Environ Health. 2016 Oct;219(7 Pt B):681-692. doi: 10.1016/j.ijheh.2016.07.017. Epub 2016 Jul 26.